These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 21086040)

  • 1. No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk in German population.
    Zhang C; Zhou P; Li JP
    Breast Cancer Res Treat; 2011 Feb; 126(1):257-9. PubMed ID: 21086040
    [No Abstract]   [Full Text] [Related]  

  • 2. No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk.
    Dünnebier T; Schlaefer K; Gilbert M; Baisch C; Justenhoven C; Brauch H; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
    Breast Cancer Res Treat; 2011 May; 127(1):259-64. PubMed ID: 20936341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Scrib, a tumor suppressor gene involved in cell polarity].
    Osmani N; Etienne-Manneville S
    Med Sci (Paris); 2008 Jan; 24(1):61-4. PubMed ID: 18198112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of Breast Cancer With Worsened Survival.
    Metodieva G; Adoki S; Lausen B; Metodiev MV
    EBioMedicine; 2016 Jun; 8():150-158. PubMed ID: 27428426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population.
    Hartikainen JM; Tuhkanen H; Kataja V; Eskelinen M; Uusitupa M; Kosma VM; Mannermaa A
    Clin Cancer Res; 2006 Mar; 12(5):1454-62. PubMed ID: 16533768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer.
    Apaydin I; Konac E; Onen HI; Akbaba M; Tekin E; Ekmekci A
    Arch Med Res; 2008 Apr; 39(3):338-45. PubMed ID: 18279708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.
    Chen P; Liang J; Wang Z; Zhou X; Chen L; Li M; Xie D; Hu Z; Shen H; Wang H
    Clin Cancer Res; 2008 Sep; 14(18):5931-7. PubMed ID: 18794107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese superoxide dismutase Ala-9Val polymorphism, environmental modifiers, and risk of breast cancer in a German population.
    Slanger TE; Chang-Claude J; Wang-Gohrke S
    Cancer Causes Control; 2006 Oct; 17(8):1025-31. PubMed ID: 16933053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of NCOA3 polymorphisms with breast cancer risk.
    Burwinkel B; Wirtenberger M; Klaes R; Schmutzler RK; Grzybowska E; Försti A; Frank B; Bermejo JL; Bugert P; Wappenschmidt B; Butkiewicz D; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Bartram CR; Hemminki K
    Clin Cancer Res; 2005 Mar; 11(6):2169-74. PubMed ID: 15788663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations.
    Medici V; Mascheretti S; Croucher PJ; Stoll M; Hampe J; Grebe J; Sturniolo GC; Solberg C; Jahnsen J; Moum B; Schreiber S; Vatn MH
    Eur J Hum Genet; 2006 Apr; 14(4):459-68. PubMed ID: 16493449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast.
    Schagdarsurengin U; Seidel C; Ulbrich EJ; Kölbl H; Dittmer J; Dammann R
    Int J Oncol; 2005 Jul; 27(1):185-91. PubMed ID: 15942659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor variants and breast cancer risk in the Polish population.
    Gapska P; Scott RJ; Serrano-Fernandez P; Huzarski T; Byrski T; Kładny J; Gronwald J; Górski B; Cybulski C; Lubinski J; Debniak T
    Breast Cancer Res Treat; 2009 Jun; 115(3):629-33. PubMed ID: 18587672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk.
    Kuschel B; Chenevix-Trench G; Spurdle AB; Chen X; Hopper JL; Giles GG; McCredie M; Chang-Claude J; Gregory CS; Day NE; Easton DF; Ponder BA; Dunning AM; Pharoah PD
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1828-31. PubMed ID: 16030124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
    Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome copy number variation and breast cancer risk.
    Tchatchou S; Burwinkel B
    Cytogenet Genome Res; 2008; 123(1-4):183-7. PubMed ID: 19287154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.
    Anastas JN; Biechele TL; Robitaille M; Muster J; Allison KH; Angers S; Moon RT
    Oncogene; 2012 Aug; 31(32):3696-708. PubMed ID: 22179838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy.
    Rajkumar T; Samson M; Rama R; Sridevi V; Mahji U; Swaminathan R; Nancy NK
    Breast Cancer Res Treat; 2008 Nov; 112(1):81-7. PubMed ID: 18058229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor Scrib interacts with the zyxin-related protein LPP, which shuttles between cell adhesion sites and the nucleus.
    Petit MM; Meulemans SM; Alen P; Ayoubi TA; Jansen E; Van de Ven WJ
    BMC Cell Biol; 2005 Jan; 6(1):1. PubMed ID: 15649318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
    Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.